1. Home
  2. SMX vs AMPH Comparison

SMX vs AMPH Comparison

Compare SMX & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SMX (Security Matters) Public Limited Company

SMX

SMX (Security Matters) Public Limited Company

HOLD

Current Price

$50.60

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$27.13

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMX
AMPH
Founded
N/A
1996
Country
Ireland
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
SMX
AMPH
Price
$50.60
$27.13
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$31.00
AVG Volume (30 Days)
1.4M
375.1K
Earning Date
04-23-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.27
Revenue
N/A
$723,305,000.00
Revenue This Year
N/A
$1.35
Revenue Next Year
N/A
$5.10
P/E Ratio
N/A
$11.91
Revenue Growth
N/A
N/A
52 Week Low
$3.12
$20.39
52 Week High
$66,187.38
$39.01

Technical Indicators

Market Signals
Indicator
SMX
AMPH
Relative Strength Index (RSI) 42.32 55.28
Support Level $110.11 $26.26
Resistance Level $198.00 $27.23
Average True Range (ATR) 40.39 0.76
MACD -15.11 0.06
Stochastic Oscillator 2.05 85.96

Price Performance

Historical Comparison
SMX
AMPH

About SMX SMX (Security Matters) Public Limited Company

SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: